Most Read Articles
6 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
6 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

3 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.

PPI use in type 2 diabetes may exacerbate hip fracture risk

06 Sep 2020

Type 2 diabetes mellitus (T2DM) patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.

The retrospective, population-based analysis included 398,885 T2DM patients. After propensity score matching, 44,431 PPI users (mean age, 59.23±12.56 years; 57.2 percent male) were included in the analysis and compared to 177,364 non-users (mean age, 58.95±12.71 years; 57.2 percent male). The primary outcome was the development of hip fractures.

Over the follow-up period, 683 cases of hip fractures occurred in the PPI group, corresponding to an incidence rate of 1.54 percent. In comparison, 1,808 such episodes were reported in the non-PPI comparators, with a rate of 1.02 percent.

Cox proportional hazards regression models found that the use of PPIs significantly increased the risk of sustaining hip fractures (hazard ratio [HR], 1.41, 95 percent confidence interval [CI], 1.29–1.54; p<0.001). The statistical model was adjusted for comorbidities and medications. Sex also appeared to be an important factor, such that males saw a lower hip fracture risk than females (HR, 0.65, 95 percent CI, 0.60–0.70; p<0.001).

The researchers then grouped the PPI patients according to their defined daily dose (DDD): nonuse (<28 DDD; n=177,364), 28–65 DDD (n=14,985), 66–124 DDD (n=14,608), and >125 DDD (n=14,748). Compared with the lowest category of cumulative dose of PPI, all other DDDs conferred a higher risk of hip fractures, though without a trend indicative of a dose-response relationship.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
6 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

3 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.